CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for 22nd Century Group Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

22nd Century Group Inc
8560 Main St Ste 4
Phone: (716) 270-1523p:716 270-1523 WILLIAMSVILLE, NY  14221-7435  United States Ticker: XXIIXXII
Business Summary
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco. Its tobacco segment is engaged in contract manufacturing organization (CMO) customer contracts that consist of obligations to manufacture the customers' branded filtered cigars and cigarettes. The tobacco segment is engaged in the sale of its reduced nicotine content (RNC) cigarettes, sold under the brand name VLN, or research cigarettes sold under the brand name SPECTRUM. It uses plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Industries
SIC Code Description
2111 Cigarettes
8731 Commercial physical and biological research
1400 Mining and quarrying of nonmetallic minerals, except fuels

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Lawrence D.Firestone 62 11/28/2023 11/28/2023
Chief Financial Officer R. HughKinsman 56 6/15/2022 6/15/2022
General Counsel JonathanStaffeldt 42 4/6/2024 4/6/2024
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
RX Pharmatech Ltd 10 Rowan Trade Park, Neville Road Bradford United Kingdom
GVB Biopharma 4456 E Craig Rd Las Vegas NV United States

Business Names
Business Name
22nd Century Group Canada, Inc.
22nd Century Group Europe B.V.
22nd CENTURY GROUP, INC.
14 additional Business Names available in full report.

General Information
Number of Employees: 64 (As of 12/31/2023)
Outstanding Shares: 5,603,278 (As of 4/8/2024)
Shareholders: 122
Stock Exchange: NASD
Federal Tax Id: 980468420
Fax Number: (716) 877-3064


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024